{"id":4113,"date":"2022-06-20T11:56:00","date_gmt":"2022-06-20T11:56:00","guid":{"rendered":"https:\/\/www.bonnier.com\/?post_type=news&p=4113"},"modified":"2022-09-08T11:56:25","modified_gmt":"2022-09-08T11:56:25","slug":"bonnier-ventures-invests-in-diagnostics-company-elypta","status":"publish","type":"news","link":"https:\/\/www.bonnier.com\/en\/news\/bonnier-ventures-invests-in-diagnostics-company-elypta\/","title":{"rendered":"Bonnier Ventures invests in diagnostics company Elypta"},"content":{"rendered":"\n

Bonnier Ventures has become a minority owner in the Swedish diagnostics company Elypta. The company focuses on developing cutting-edge technology that uses liquid biopsies to detect early-stage cancer. 
\u201cWe believe Elypta has huge potential to improve healthcare,\u201d says Sofia Hasselberg, Investment Director at Bonnier Ventures.<\/p>\n\n\n\n

Bonnier Ventures<\/a>‘ acquisition of a significant minority stake in  Elypta<\/a> is in line with its investment priority areas of health tech and precision medicine.<\/p>\n\n\n\n

Elypta was founded in 2017 to develop the world’s first blood- and urine-test technology based on human metabolic biomarkers, for early detection and more frequent follow-up of cancer.<\/p>\n\n\n\n

\u201cBonnier Ventures is proud to support Elypta\u2019s strong team in their continued work. Through scientific innovation and software development, Elypta contributes to solving one of healthcare\u2019s major challenges: reducing cancer mortality. The technology Elypta is developing is unique and enables the detection of many cancers before symptoms start to appear. In addition, Elypta’s technology does this in a cost-effective way that we have not seen before in the global healthcare market,\u201d says Sofia Hasselberg<\/strong> of Bonnier Ventures.<\/p>\n\n\n\n

The financing round for Elypta was led by Bonnier Ventures, in which existing shareholders Navigare Ventures, Industrifonden, Hillclimber, Norrsken VC, Nina Capital and Chalmers Ventures, among others, also participated.<\/p>\n\n\n\n

Elypta will use the capital to develop and validate blood and urine tests for Multi-Cancer Early Detection (MCED) in adults with no symptoms of cancer and for detection of recurrence in kidney cancer patients.<\/p>\n\n\n\n

\u201cWe are delighted to now have Bonnier Ventures among our owners. They are a financially strong, long-term investor adding significant networks and industry expertise to Elypta,\u201d says Karl Bergman<\/strong>, CEO of Elypta.<\/p>\n\n\n\n

\u201cOur MCED test has the potential to greatly improve the share of cancers detected at the earliest stages, when treatment is more effective as well as less costly. Detecting Stage I cancer has been a particular challenge for DNA-based tests, and this is where metabolism-based biomarkers could really make a difference.\u201d <\/p>\n\n\n\n

For more information contact:<\/strong><\/p>\n\n\n\n

Sofia Hasselberg<\/a>, Investment Director, Bonnier Ventures
tel: +46 70 916 37 60.<\/p>\n\n\n\n

Karl Bergman<\/a>, CEO, Elypta,
tel: +46 73 262 53 33.<\/p>\n","protected":false},"excerpt":{"rendered":"

Bonnier Ventures has become a minority owner in the Swedish diagnostics company Elypta. The company focuses on developing cutting-edge technology that uses liquid biopsies to detect early-stage cancer. \u201cWe believe Elypta has huge potential to improve healthcare,\u201d says Sofia Hasselberg, Investment Director at Bonnier Ventures. Bonnier Ventures‘ acquisition of a significant minority stake in  Elypta is in line with […]<\/p>\n","protected":false},"author":1,"featured_media":4111,"template":"","meta":{"_acf_changed":false},"tags":[935,937,936],"class_list":["post-4113","news","type-news","status-publish","has-post-thumbnail","hentry","tag-elypta-2","tag-investments-2","tag-karl-bergman-2"],"acf":[],"yoast_head":"\nBonnier - Bonnier Ventures invests in diagnostics company Elypta<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.bonnier.com\/en\/news\/bonnier-ventures-invests-in-diagnostics-company-elypta\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bonnier - Bonnier Ventures invests in diagnostics company Elypta\" \/>\n<meta property=\"og:description\" content=\"Bonnier Ventures has become a minority owner in the Swedish diagnostics company Elypta. The company focuses on developing cutting-edge technology that uses liquid biopsies to detect early-stage cancer. \u201cWe believe Elypta has huge potential to improve healthcare,\u201d says Sofia Hasselberg, Investment Director at Bonnier Ventures. Bonnier Ventures‘ acquisition of a significant minority stake in  Elypta is in line with […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.bonnier.com\/en\/news\/bonnier-ventures-invests-in-diagnostics-company-elypta\/\" \/>\n<meta property=\"og:site_name\" content=\"Bonnier\" \/>\n<meta property=\"article:modified_time\" content=\"2022-09-08T11:56:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.bonnier.com\/wp-content\/uploads\/2022\/09\/elypta_m.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"960\" \/>\n\t<meta property=\"og:image:height\" content=\"536\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.bonnier.com\\\/en\\\/news\\\/bonnier-ventures-invests-in-diagnostics-company-elypta\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bonnier.com\\\/en\\\/news\\\/bonnier-ventures-invests-in-diagnostics-company-elypta\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.bonnier.com\\\/#\\\/schema\\\/person\\\/92f77a1e13e7509c5c3214a574b2a88d\"},\"headline\":\"Bonnier Ventures invests in diagnostics company Elypta\",\"datePublished\":\"2022-06-20T11:56:00+00:00\",\"dateModified\":\"2022-09-08T11:56:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.bonnier.com\\\/en\\\/news\\\/bonnier-ventures-invests-in-diagnostics-company-elypta\\\/\"},\"wordCount\":354,\"image\":{\"@id\":\"https:\\\/\\\/www.bonnier.com\\\/en\\\/news\\\/bonnier-ventures-invests-in-diagnostics-company-elypta\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bonnier.com\\\/wp-content\\\/uploads\\\/2022\\\/09\\\/elypta_m.jpeg\",\"keywords\":[\"Elypta\",\"investments\",\"Karl Bergman\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.bonnier.com\\\/en\\\/news\\\/bonnier-ventures-invests-in-diagnostics-company-elypta\\\/\",\"url\":\"https:\\\/\\\/www.bonnier.com\\\/en\\\/news\\\/bonnier-ventures-invests-in-diagnostics-company-elypta\\\/\",\"name\":\"Bonnier - Bonnier Ventures invests in diagnostics company Elypta\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bonnier.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.bonnier.com\\\/en\\\/news\\\/bonnier-ventures-invests-in-diagnostics-company-elypta\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bonnier.com\\\/en\\\/news\\\/bonnier-ventures-invests-in-diagnostics-company-elypta\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bonnier.com\\\/wp-content\\\/uploads\\\/2022\\\/09\\\/elypta_m.jpeg\",\"datePublished\":\"2022-06-20T11:56:00+00:00\",\"dateModified\":\"2022-09-08T11:56:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.bonnier.com\\\/en\\\/news\\\/bonnier-ventures-invests-in-diagnostics-company-elypta\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.bonnier.com\\\/en\\\/news\\\/bonnier-ventures-invests-in-diagnostics-company-elypta\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.bonnier.com\\\/en\\\/news\\\/bonnier-ventures-invests-in-diagnostics-company-elypta\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.bonnier.com\\\/wp-content\\\/uploads\\\/2022\\\/09\\\/elypta_m.jpeg\",\"contentUrl\":\"https:\\\/\\\/www.bonnier.com\\\/wp-content\\\/uploads\\\/2022\\\/09\\\/elypta_m.jpeg\",\"width\":960,\"height\":536},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.bonnier.com\\\/en\\\/news\\\/bonnier-ventures-invests-in-diagnostics-company-elypta\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.bonnier.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.bonnier.com\\\/en\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Bonnier Ventures invests in diagnostics company Elypta\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.bonnier.com\\\/#website\",\"url\":\"https:\\\/\\\/www.bonnier.com\\\/\",\"name\":\"Bonnier\",\"description\":\"Nordens ledande medief\u00f6retag\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.bonnier.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.bonnier.com\\\/#\\\/schema\\\/person\\\/92f77a1e13e7509c5c3214a574b2a88d\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/31f2a46c4639ddb71a67f2ce8afe82386e36d06d48e498b84e0ddfa372bbbe5d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/31f2a46c4639ddb71a67f2ce8afe82386e36d06d48e498b84e0ddfa372bbbe5d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/31f2a46c4639ddb71a67f2ce8afe82386e36d06d48e498b84e0ddfa372bbbe5d?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"http:\\\/\\\/www.bonnier.com\\\/wp\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bonnier - Bonnier Ventures invests in diagnostics company Elypta","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.bonnier.com\/en\/news\/bonnier-ventures-invests-in-diagnostics-company-elypta\/","og_locale":"en_US","og_type":"article","og_title":"Bonnier - Bonnier Ventures invests in diagnostics company Elypta","og_description":"Bonnier Ventures has become a minority owner in the Swedish diagnostics company Elypta. The company focuses on developing cutting-edge technology that uses liquid biopsies to detect early-stage cancer. \u201cWe believe Elypta has huge potential to improve healthcare,\u201d says Sofia Hasselberg, Investment Director at Bonnier Ventures. Bonnier Ventures‘ acquisition of a significant minority stake in  Elypta is in line with […]","og_url":"https:\/\/www.bonnier.com\/en\/news\/bonnier-ventures-invests-in-diagnostics-company-elypta\/","og_site_name":"Bonnier","article_modified_time":"2022-09-08T11:56:25+00:00","og_image":[{"width":960,"height":536,"url":"https:\/\/www.bonnier.com\/wp-content\/uploads\/2022\/09\/elypta_m.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.bonnier.com\/en\/news\/bonnier-ventures-invests-in-diagnostics-company-elypta\/#article","isPartOf":{"@id":"https:\/\/www.bonnier.com\/en\/news\/bonnier-ventures-invests-in-diagnostics-company-elypta\/"},"author":{"name":"admin","@id":"https:\/\/www.bonnier.com\/#\/schema\/person\/92f77a1e13e7509c5c3214a574b2a88d"},"headline":"Bonnier Ventures invests in diagnostics company Elypta","datePublished":"2022-06-20T11:56:00+00:00","dateModified":"2022-09-08T11:56:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.bonnier.com\/en\/news\/bonnier-ventures-invests-in-diagnostics-company-elypta\/"},"wordCount":354,"image":{"@id":"https:\/\/www.bonnier.com\/en\/news\/bonnier-ventures-invests-in-diagnostics-company-elypta\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bonnier.com\/wp-content\/uploads\/2022\/09\/elypta_m.jpeg","keywords":["Elypta","investments","Karl Bergman"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.bonnier.com\/en\/news\/bonnier-ventures-invests-in-diagnostics-company-elypta\/","url":"https:\/\/www.bonnier.com\/en\/news\/bonnier-ventures-invests-in-diagnostics-company-elypta\/","name":"Bonnier - Bonnier Ventures invests in diagnostics company Elypta","isPartOf":{"@id":"https:\/\/www.bonnier.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.bonnier.com\/en\/news\/bonnier-ventures-invests-in-diagnostics-company-elypta\/#primaryimage"},"image":{"@id":"https:\/\/www.bonnier.com\/en\/news\/bonnier-ventures-invests-in-diagnostics-company-elypta\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bonnier.com\/wp-content\/uploads\/2022\/09\/elypta_m.jpeg","datePublished":"2022-06-20T11:56:00+00:00","dateModified":"2022-09-08T11:56:25+00:00","breadcrumb":{"@id":"https:\/\/www.bonnier.com\/en\/news\/bonnier-ventures-invests-in-diagnostics-company-elypta\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.bonnier.com\/en\/news\/bonnier-ventures-invests-in-diagnostics-company-elypta\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.bonnier.com\/en\/news\/bonnier-ventures-invests-in-diagnostics-company-elypta\/#primaryimage","url":"https:\/\/www.bonnier.com\/wp-content\/uploads\/2022\/09\/elypta_m.jpeg","contentUrl":"https:\/\/www.bonnier.com\/wp-content\/uploads\/2022\/09\/elypta_m.jpeg","width":960,"height":536},{"@type":"BreadcrumbList","@id":"https:\/\/www.bonnier.com\/en\/news\/bonnier-ventures-invests-in-diagnostics-company-elypta\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.bonnier.com\/en\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.bonnier.com\/en\/news\/"},{"@type":"ListItem","position":3,"name":"Bonnier Ventures invests in diagnostics company Elypta"}]},{"@type":"WebSite","@id":"https:\/\/www.bonnier.com\/#website","url":"https:\/\/www.bonnier.com\/","name":"Bonnier","description":"Nordens ledande medief\u00f6retag","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.bonnier.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.bonnier.com\/#\/schema\/person\/92f77a1e13e7509c5c3214a574b2a88d","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/31f2a46c4639ddb71a67f2ce8afe82386e36d06d48e498b84e0ddfa372bbbe5d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/31f2a46c4639ddb71a67f2ce8afe82386e36d06d48e498b84e0ddfa372bbbe5d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/31f2a46c4639ddb71a67f2ce8afe82386e36d06d48e498b84e0ddfa372bbbe5d?s=96&d=mm&r=g","caption":"admin"},"sameAs":["http:\/\/www.bonnier.com\/wp"]}]}},"_links":{"self":[{"href":"https:\/\/www.bonnier.com\/en\/wp-json\/wp\/v2\/news\/4113","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bonnier.com\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.bonnier.com\/en\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.bonnier.com\/en\/wp-json\/wp\/v2\/users\/1"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bonnier.com\/en\/wp-json\/wp\/v2\/media\/4111"}],"wp:attachment":[{"href":"https:\/\/www.bonnier.com\/en\/wp-json\/wp\/v2\/media?parent=4113"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bonnier.com\/en\/wp-json\/wp\/v2\/tags?post=4113"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}